Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010
about
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationUse of prescription drug claims data to identify lipid-lowering medication exposure in pharmacoepidemiology studies: potential pitfalls.Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data.Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease.Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).Is the risk of Alzheimer's disease and dementia declining?Complementary Cholesterol-Lowering Response of a Phytosterol/α-Lipoic Acid Combination in Obese Zucker Rats.Trends in myocardial infarction secondary prevention: The National Health and Nutrition Examination Surveys (NHANES), 1999-2012.High Cholesterol Awareness, Treatment, and Control Among Hispanic/Latinos: Results From the Hispanic Community Health Study/Study of Latinos.Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational StudiesCardiovascular Risk in Midlife African American Women Participating in a Lifestyle Physical Activity Program.Prevalence of Major Cardiovascular Risk Factors and Coronary Heart Disease in a Sample of Greek Adults: The Saronikos Study.Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.Determinants of prevalence, awareness, treatment and control of high LDL-C in Turkey.Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009.Statin prescribing for people with severe mental illnesses: a staggered cohort study of 'real-world' impacts.Adherence to statin therapy in patients with type 2 diabetes: An important dilemma.Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network.Opportunities for improving cardiovascular health outcomes in adults younger than 65 years with guideline-recommended statin therapy.Taking care of volunteers in a stroke trial: a new assisted-management strategy.Automated Outreach for Cardiovascular-Related Medication Refill Reminders.Failure to control hypercholesterolaemia in the Irish adult population: cross-sectional analysis of the baseline wave of The Irish Longitudinal Study on Ageing (TILDA).Awareness of Cardiovascular Risk Factors in U.S. Young Adults Aged 18-39 Years.Disseminating, implementing, and evaluating patient-centered outcomes to improve cardiovascular care using a stepped-wedge design: healthy hearts for Oklahoma.
P2860
Q30238784-17F83EB2-7E55-4673-BF94-F0D8B6AE1362Q31090652-1B3A43BB-243C-4449-9394-03C239A40246Q31113251-91802554-7A6F-4B1F-A305-9C1F256ED1ACQ33940584-0D4BE4BE-F3EF-4007-A688-688BE61DB0EBQ34307407-457BDE30-9D3D-488A-B5DA-C937AA709D06Q34364029-4F03D509-295D-4C32-856B-2169345DDA64Q35218601-8BC19FC4-4263-4613-AC2D-89FD4A47B7ADQ35931637-157478FB-B6F0-47D2-B119-FA43B3471C83Q36085798-EAC81DBA-7425-415F-9DAE-EB88BB0898F2Q36168724-02C1D748-08B2-45FF-995F-6E11DDE6C255Q36479927-730B361F-F79C-4514-90EF-79BE4C74EF81Q36803879-912404CD-AD89-4543-8C18-B43BE193B4B2Q37096270-63918D0A-E371-49D2-8733-6D09485D5B18Q37291832-CAB2CCC3-5023-4FA0-B01F-6C53DF0CCBB1Q37672899-993AD960-B29A-4266-B5E2-DC114562D18DQ37700758-8A09C3F4-34E3-4C2A-9FD3-E881E8B623D0Q37704226-019EB510-4160-4EBD-9360-4775F50373AEQ39725731-5AE9FC70-4223-467B-8B9E-FC73340B4974Q40142545-E4645612-DB65-4AD6-9317-8F6460071753Q40211444-D0E159D3-3008-4DDC-B928-098B0ADE7061Q41678642-07D8C49D-1A4E-4D0F-BD74-76D77EAAE566Q45995752-0B44A17C-E58B-4AA5-951B-E344A2140A5BQ47151571-B1BC3E05-6833-448C-9AD1-12278EED1727Q50056580-24FEB081-1CD2-4A6B-B13E-67F092269561Q55471254-FB37AD76-6ABD-42EE-9214-205CBDD43A21
P2860
Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trends in the prevalence, awar ...... om 1999-2000 through 2009-2010
@en
Trends in the prevalence, awar ...... m 1999-2000 through 2009-2010.
@nl
type
label
Trends in the prevalence, awar ...... om 1999-2000 through 2009-2010
@en
Trends in the prevalence, awar ...... m 1999-2000 through 2009-2010.
@nl
prefLabel
Trends in the prevalence, awar ...... om 1999-2000 through 2009-2010
@en
Trends in the prevalence, awar ...... m 1999-2000 through 2009-2010.
@nl
P2093
P2860
P1476
Trends in the prevalence, awar ...... om 1999-2000 through 2009-2010
@en
P2093
Emily B Levitan
Huifeng Yun
J Michael Woolley
Meredith Kilgore
Michael E Farkouh
Paul Muntner
Pradeep Sharma
Robert S Rosenson
Stephen Glasser
P2860
P304
P356
10.1016/J.AMJCARD.2013.04.041
P407
P50
P577
2013-05-29T00:00:00Z